Management soon after a stroke

Drug and Therapeutics Bulletin

Volumn 36, Issue 7, 1998, Pages 51-54

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; LUBELUZOLE; NEUROPROTECTIVE AGENT; STREPTOKINASE;

ARTICLE; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN INFARCTION; CLINICAL FEATURE; HOSPITAL ADMISSION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MORTALITY; PATHOLOGY; PATIENT CARE; RECURRENT DISEASE; STROKE; SUBARACHNOID HEMORRHAGE; UNITED KINGDOM;

EID: 0031849110     PISSN: 00126543     EISSN: None     Source Type: Journal    
DOI: 10.1136/dtb.1998.36751     Document Type: Article

References (41)

1. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C. A prospective study of acute cerebrovascular disease in the community: the Oxfordshire Community Stroke Project - 1981-86. J Neurol Neurosurg Psychiatry 1990; 53: 16-22.
2. CAST (Chinese Acute Stroke Trial) Collaborative Group. CAST: randomised placebo-controlled trial of early aspirin use in 20 000 patients with acute ischaemic stroke. Lancet 1997; 349: 1641-9.
3. International Stroke Trial Collaborative Group. The International Stroke Trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19 435 patients with acute ischaemic stroke. Lancet 1997; 349: 1569-81.
4. Sandercock P, Tangkanakul C. Very early prevention of stroke recurrence. Cerebrovasc Dis 1997; 7 (suppl 1): 10-5.
5. Bamford J, Dennis M, Sandercock P, Burn J, Warlow C. The frequency, causes and timing of death within 30 days of a first stroke: the Oxfordshire Community Stroke Project.J Neurol Neurosurg Psychiatry 1990; 53: 824-9.
6. Warlow CP, Dennis MS, van Gijn J et al. Stroke. A practical guide to management. Oxford: Blackwell Science Ltd, 1996; 545-97.
7. Scottish Intercollegiate Guideline Network. Management of patients with stroke. III: Identification and management of dysphagia. A national clinical guideline recommended for use in Scotland. Pilot Edition. Edinburgh: SIGN, 1997.
8. Warlow CP, Dennis MS, van Gijn J et al. Stroke. A practical guide to management. Oxford: Blackwell Science Ltd, 1996; 146-89.
9. Weir CJ, Murray GD, Adams FG, Muir KW, Grosset DG, Lees KR. Poor accuracy of stroke scoring systems for differential clinical diagnosis of intracranial haemorrhage and infarction. Lancet 1994; 344: 999-1002.
10. Scottish Intercollegiate Guidelines Network.Management of patients with stroke. I: Assessment, investigation, immediate management and secondary prevention. A national clinical guideline recommended for use in Scotland. Pilot Edition. Edinburgh: SIGN, 1997.
11. Managing carotid stenosis. DTB 1998; 36: 9-12.
12. Bath PMW, Soo J, Butterworth RJ, Kerr JE. Do acute stroke units improve care? Cerebrovasc Dis 1996; 6: 346-9.
13. Rønning OM, Guldvog B. Stroke units versus general medical wards, I: twelve- and eighteen-month survival. A randomized, controlled trial. Stroke 1998; 29:58-62.
14. Stroke Unit Trialists' Collaboration. Collaborative systematic review of the randomised trials of organised inpatient (stroke unit) care after stroke. BMJ 1997; 314: 1151-9.
15. Rudd AG, Wolfe CDA, Tilling K, Beech R. Randomised controlled trial to evaluate early discharge scheme for patients with stroke. BMJ 1997; 315: 1039-44.
16. Rodgers H, Soutter J, Kaiser W et al. Early supported hospital discharge following acute stroke: pilot study results. Clin Rehabil 1997; 11: 280-7.
17. Hankey GJ, Hon C. Surgery for primary intracerebral hemorrhage: is it safe and effective? A systematic review of case series and randomized trials. Stroke 1997; 28: 2126-32.
18. Prasad K, Browman G, Srivastava A, Menon G. Surgery in primary supratentorial intracerebral hematoma: a meta-analysis of randomized trials. Acta Neurol Scand 1997; 95: 103-10.
19. Antiplatelet Trialists' Collaboration. Collaborative overview of randomised trials of antiplatelet therapy - I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 1994; 308: 81-106.
20. Aspirin to prevent heart attack or stroke. DTB 1994; 32: 1-3.
21. Which prophylactic aspirin? DTB 1997; 35: 7-8.
22. Counsell C, Sandercock P. Anticoagulant therapy compared to control in patients with acute presumed ischaemic stroke (Cochrane Review). In: The Cochrane Library, Issue 2, 1998. Oxford: Update Software.
23. Counsell C, Sandercock P. The use of low-molecular-weight heparins or heparinoids compared to standard unfractionated heparin in acute ischaemic stroke (Cochrane Review). In: The Cochrane Library, Issue 2, 1998. Oxford: Update Software.
24. Warfarin or aspirin for non-rheumatic atrial fibrillation? DTB 1994; 32: 57-60.
25. Koudstaal P. Secondary prevention following stroke or transient ischemic attack in patients with nonrheumatic atrial fibrillation: anticoagulant therapy versus control (Cochrane Review). In: The Cochrane Library, Issue 2, 1998. Oxford: Update Software.
26. Royal College of Physicians of Edinburgh. Consensus statement. Consensus conference on medical management of stroke 26 & 27 May 1998.
27. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke. A randomized controlled trial.JAMA 1998; 279: 1265-72.
28. Hommel M for the FISS bis Investigators Group. Fraxiparine in ischaemic stroke study (FISS bis). Cerebrovasc Dis 1998; 8 (suppl 4): 19 [abstract 64].
29. Wardlaw JM, Warlow CP, Counsell C. Systematic review of evidence on thrombolytic therapy for acute ischaemic stroke.Lancet 1997; 350: 607-14.
30. Adams Jr HP, Brott TG, Furlan AJ et al. Guidelines for thrombolytic therapy for acute stroke: a supplement to the guidelines for the management of patients with acute ischemic stroke. A statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association.Stroke 1996; 27: 1711-8.
31. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995; 333: 1581-7.
32. Hacke W, Kaste M, Fieschi C et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 1995; 274: 1017-25.
33. Blood pressure in Acute Stroke Collaboration (BASC). Blood pressure management in acute stroke. Part I: assessment of trials designed to alter blood pressure (Cochrane Review). In : The Cochrane Library, Issue 2, 1998. Oxford: Update Software.
34. O'Connell JE, Gray CS. Treating hypertension after stroke.BMJ 1994; 308: 1523-4.
35. Weir CJ, Murray GD, Dyker AG, Lees KR. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study. BMJ 1997; 314: 1303-6.
36. Asplund K, Israelsson K, Schampi I. Haemodilution in acute ischaemic stroke (Cochrane Review). In: The Cochrane Library, Issue 2, 1998. Oxford: Update Software.
37. Qizilbash N, Lewington SL, Lopez-Arrieta JM. Corticosteroids following acute presumed ischaemic stroke (Cochrane Review). In: The Cochrane Library, Issue 2, 1998. Oxford: Update Software.
38. a' Rogvi-Hansen B, Boysen G. Glycerol treatment in acute ischaemic stroke (Cochrane Review). In: The Cochrane Library, Issue 2, 1998. Oxford: Update Software.
39. Diener HC, Hacke W, Hennerici M, Rådberg J, Hantson L, De Keyser J for the Lubeluzole International Study Group. Lubeluzole in acute ischemic stroke. A double-blind, placebo-controlled phase II trial. Stroke 1996; 27: 76-81.
40. Diener HC for the European and Australian Lubeluzole Ischaemic Stroke Study Group. Multinational randomised controlled trial of lubeluzole in acute ischaemic stroke. Cerebrovasc Dis 1998; 8: 172-81.
41. Grotta J for the US and Canadian Lubeluzole Ischemic Stroke Study Group. Lubeluzole treatment of acute ischemic stroke. Stroke 1997; 28: 2338-46.